Illumina to buy SomaLogic for up to $425M
Illumina said adding SomaLogic would support the company’s multiomics strategy and strengthen the value of its NovaSeq X products.


Illumina said adding SomaLogic would support the company’s multiomics strategy and strengthen the value of its NovaSeq X products.